Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe.
Molecular Diagnostics Market Trends:
Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end users.
Breakup by Product:
Reagents and Kits
Instruments
Software and Services
Breakup by Technology:
Polymerase Chain Reactions (PCR)
Hybridization
DNA Sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Breakup by Application:
Infectious Diseases Diagnostics
Oncology
Genetic Testing
Blood Screening
Others
Breakup by End Users:
Hospitals
Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.
Key Questions Answered in This Report:
How has the global molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global molecular diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end users?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global molecular diagnostics market and who are the key players?
What is the degree of competition in the industry?
The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe.
Molecular Diagnostics Market Trends:
Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end users.
Breakup by Product:
Reagents and Kits
Instruments
Software and Services
Breakup by Technology:
Polymerase Chain Reactions (PCR)
Hybridization
DNA Sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Breakup by Application:
Infectious Diseases Diagnostics
Oncology
Genetic Testing
Blood Screening
Others
Breakup by End Users:
Hospitals
Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.
Key Questions Answered in This Report:
How has the global molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global molecular diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end users?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global molecular diagnostics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL MOLECULAR DIAGNOSTICS MARKET
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1Reagents and Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1Polymerase Chain Reactions (PCR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Hybridization
7.2.1 Market Trends
7.2.2 Market Forecast
7.3DNA Sequencing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4Microarray
7.4.1 Market Trends
7.4.2 Market Forecast
7.5Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5.1 Market Trends
7.5.2 Market Forecast
7.6Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1Infectious Diseases Diagnostics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Oncology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Genetic Testing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4Blood Screening
8.4.1 Market Trends
8.4.2 Market Forecast
8.5Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USERS
9.1Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1Overview
11.2Strengths
11.3Weaknesses
11.4Opportunities
11.5Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1Overview
13.2Bargaining Power of Buyers
13.3Bargaining Power of Suppliers
13.4Degree of Competition
13.5Threat of New Entrants
13.6Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1Market Structure
15.2Key Players
15.3Profiles of Key Players
15.3.1Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3Becton Dickinson and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4Biomerieux SA
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5Danaher Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6Diasorin Molecular LLC (DiaSorin S.p.A.)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7F. Hoffmann-La Roche AG (Roche Holding AG)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.8Hologic Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9Illumina Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11Qiagen
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12Quidel Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13Thermo Fisher Scientific
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL MOLECULAR DIAGNOSTICS MARKET
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1Reagents and Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1Polymerase Chain Reactions (PCR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Hybridization
7.2.1 Market Trends
7.2.2 Market Forecast
7.3DNA Sequencing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4Microarray
7.4.1 Market Trends
7.4.2 Market Forecast
7.5Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5.1 Market Trends
7.5.2 Market Forecast
7.6Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1Infectious Diseases Diagnostics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Oncology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Genetic Testing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4Blood Screening
8.4.1 Market Trends
8.4.2 Market Forecast
8.5Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USERS
9.1Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1Overview
11.2Strengths
11.3Weaknesses
11.4Opportunities
11.5Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1Overview
13.2Bargaining Power of Buyers
13.3Bargaining Power of Suppliers
13.4Degree of Competition
13.5Threat of New Entrants
13.6Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1Market Structure
15.2Key Players
15.3Profiles of Key Players
15.3.1Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3Becton Dickinson and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4Biomerieux SA
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5Danaher Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6Diasorin Molecular LLC (DiaSorin S.p.A.)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7F. Hoffmann-La Roche AG (Roche Holding AG)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.8Hologic Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9Illumina Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11Qiagen
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12Quidel Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13Thermo Fisher Scientific
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2023-2028
Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Molecular Diagnostics Market: Key Players
Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2023-2028
Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Molecular Diagnostics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2022
Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2022
Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis
Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2022
Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2022
Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis
